Jane Street Group, LLC Novavax Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 1,838,807 shares of NVAX stock, worth $16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,838,807

Previous 1,883,537 2.37%

Holding current value

$16 Million

Previous $23.8 Million 2.6%

% of portfolio

0.01%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $479,058 - $765,330	-44,730 Reduced 2.37%	1,838,807 $23.2 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $6.97 Million - $37.6 Million	1,791,857 Added 1954.47%	1,883,537 $23.8 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $3.78 Million - $6.05 Million	-1,004,825 Reduced 91.64%	91,680 $438,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $3.4 Million - $5.44 Million	709,291 Added 183.18%	1,096,505 $5.26 Million
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $1.36 Million - $1.94 Million	-199,101 Reduced 33.96%	387,214 $2.8 Million
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $14,727 - $21,020	-2,208 Reduced 0.38%	586,315 $4.36 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $1.28 Million - $2.77 Million	221,801 Added 60.48%	588,523 $4.08 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $2.65 Million - $7.5 Million	299,358 Added 444.39%	366,722 $3.77 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $4.34 Million - $18.1 Million	-238,427 Reduced 77.97%	67,364 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $4.34 Million - $18.1 Million	-238,427 Reduced 77.97%	67,364 $1.23 Million
Q2 2022 Aug 16, 2022	SELL	$36.28 - $75.29 $9.34 Million - $19.4 Million	-257,407 Reduced 45.7%	305,791 $15.7 Million
Q1 2022 May 17, 2022	SELL	$69.73 - $142.9 $6.04 Million - $12.4 Million	-86,592 Reduced 13.33%	563,198 $41.5 Million
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $51.4 Million - $83.2 Million	381,887 Added 142.55%	649,790 $93 Million
Q3 2021 Nov 16, 2021	SELL	$177.8 - $270.58 $27.4 Million - $41.7 Million	-154,060 Reduced 36.51%	267,903 $55.5 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $34.2 Million - $72.9 Million	282,906 Added 203.45%	421,963 $89.6 Million
Q1 2021 May 18, 2021	BUY	$112.98 - $319.93 $6.46 Million - $18.3 Million	57,210 Added 69.9%	139,057 $25.2 Million
Q4 2020 Feb 17, 2021	SELL	$78.74 - $139.5 $2.06 Million - $3.64 Million	-26,124 Reduced 24.2%	81,847 $9.13 Million
Q3 2020 Nov 17, 2020	SELL	$79.44 - $178.51 $8.45 Million - $19 Million	-106,377 Reduced 49.63%	107,971 $11.7 Million
Q2 2020 Aug 17, 2020	BUY	$13.86 - $83.61 $2.58 Million - $15.5 Million	185,961 Added 655.09%	214,348 $17.9 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $111,560 - $454,192	28,387 New	28,387 $385,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Novavax Inc Transaction History